PLACEBO WASHOUT IS NOT A MEANINGFUL PART OF ANTIDEPRESSANT DRUG TRIALS

被引:21
作者
GREENBERG, RP
FISHER, S
RITER, JA
机构
[1] Department of Psychiatry and Behavioral Sciences, State University of New York Health Science Center, Syracuse
关键词
D O I
10.2466/pms.1995.81.2.688
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Most trials testing the effectiveness of psychotropic drugs begin with a placebo washout phase. Hypothetically this technique rids studies of placebo responders before randomization of subjects to drug and placebo groups. In theory, this lowers the level of response to placebo in the study and magnifies the superiority of the response to medication. An analysis of 10 years of research literature demonstrates that the washout technique does not do what it was designed to do in antidepressant studies. Within placebo or drug groups neither measures of depression nor dropouts were affected by including a preliminary washout in the design. The findings are consistent with the two other studies that have addressed this issue.
引用
收藏
页码:688 / 690
页数:3
相关论文
共 7 条
[1]   HOW SOUND IS THE DOUBLE-BLIND DESIGN FOR EVALUATING PSYCHOTROPIC-DRUGS [J].
FISHER, S ;
GREENBERG, RP .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1993, 181 (06) :345-350
[2]   SUSPENDED JUDGMENT - SEEING THROUGH THE DOUBLE-MASKED DESIGN - A COMMENTARY [J].
GREENBERG, RP ;
FISHER, S .
CONTROLLED CLINICAL TRIALS, 1994, 15 (04) :244-246
[3]  
GREENBERG RP, 1989, LIMITS BIOL TREATMEN, P1
[4]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[5]   THE INTRODUCTORY PLACEBO WASHOUT - A RETROSPECTIVE EVALUATION [J].
REIMHERR, FW ;
WARD, MF ;
BYERLEY, WF .
PSYCHIATRY RESEARCH, 1989, 30 (02) :191-199
[6]   SHOULD THE SINGLE-BLIND PLACEBO RESPONDER EXCLUSION PHASE BE OMITTED FROM CLINICAL-TRIALS [J].
SKOVLUND, E .
NORDIC JOURNAL OF PSYCHIATRY, 1994, 48 (03) :159-165
[7]   DOES A PLACEBO RUN-IN OR A PLACEBO-TREATMENT CELL AFFECT THE EFFICACY OF ANTIDEPRESSANT MEDICATIONS [J].
TRIVEDI, MH ;
RUSH, J .
NEUROPSYCHOPHARMACOLOGY, 1994, 11 (01) :33-43